Evidence map›Paper›PMID 39367397›Full record

ReviewBMC medical informatics and decision making2024

The power of deep learning in simplifying feature selection for hepatocellular carcinoma: a review.

Ghada Mostafa, Hamdi Mahmoud, Tarek Abd El-Hafeez, Mohamed E ElAraby

Abstract readReview
In one paragraph

Review in BMC medical informatics and decision making, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ghada MostafaComputer Science Department, Faculty of Computers and Artificial Intelligence, Beni-Suef University, Beni-Suef, Egypt. GhadaMostafaAbdelaziz8_pg@fcis.bsu.edu.eg.
Hamdi MahmoudComputer Science Department, Faculty of Computers and Artificial Intelligence, Beni-Suef National University, Beni-Suef, Egypt. Dr_hamdimahmoud@yahoo.com.
Tarek Abd El-HafeezDepartment of Computer Science, Faculty of Science, Minia University, EL-Minia, Egypt. tarek@mu.edu.eg.
Mohamed E ElArabyComputer Science Department, Faculty of Computers and Artificial Intelligence, Beni-Suef University, Beni-Suef, Egypt. Mohamed.elaraby@fcis.bsu.edu.eg.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHepatocellular Carcinoma (HCC) is a highly aggressive, prevalent, and deadly type of liver cancer. With the advent of deep learning techniques, significant advancements have been made in simplifying and optimizing the feature selection process.

objectiveOur scoping review presents an overview of the various deep learning models and algorithms utilized to address feature selection for HCC. The paper highlights the strengths and limitations of each approach, along with their potential applications in clinical practice. Additionally, it discusses the benefits of using deep learning to identify relevant features and their impact on the accuracy and efficiency of diagnosis, prognosis, and treatment of HCC.

designThe review encompasses a comprehensive analysis of the research conducted in the past few years, focusing on the methodologies, datasets, and evaluation metrics adopted by different studies. The paper aims to identify the key trends and advancements in the field, shedding light on the promising areas for future research and development.

resultsThe findings of this review indicate that deep learning techniques have shown promising results in simplifying feature selection for HCC. By leveraging large-scale datasets and advanced neural network architectures, these methods have demonstrated improved accuracy and robustness in identifying predictive features.

conclusionsWe analyze published studies to reveal the state-of-the-art HCC prediction and showcase how deep learning can boost accuracy and decrease false positives. But we also acknowledge the challenges that remain in translating this potential into clinical reality.

Indexed as

Carcinoma, HepatocellularDeep LearningLiver NeoplasmsHumansArtificial IntelligenceDeep LearningFeature selectionHepatocellular carcinomaLiver cancerMachine Learning

Identifiers

PMID39367397
PMCPMC11452940

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.